Safety-net health clinics cut services and staff amid Medicaid ‘unwinding’

The FDA an­nounced that it’s with­draw­ing the ap­proval of Gem­i­ni Lab­o­ra­to­ries’ an­a­bol­ic steroid Oxan­drin (oxan­drolone) and four gener­ic ver­sions, a decades-old treat­ment once in­di­cat­ed for

STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in patients who had a history of treatment with metformin, a case-control study involving